Poly-histidine peptides such as H6 (HHHHHH) are used in protein biotechnologies as purification tags, protein-assembling agents and endosomal-escape entities. The pleiotropic properties of such peptides make them appealing to design protein-based smart materials or nanoparticles for imaging or drug delivery to be produced in form of recombinant proteins. However, the clinical applicability of H6tagged proteins is restricted by the potential immunogenicity of these segments. In this study, we have explored several humanized histidine-rich peptides in tumor-targeted modular proteins, which can specifically bind and be internalized by the target cells through the tumoral marker CXCR4. We were particularly interested in exploring how protein purification, self-assembling and endosomal escape perform in proteins containing the variant histidine-rich tags. Among the tested candidates, the peptide H5E (HEHEHEHEH) is promising as a good promoter of endosomal escape of the associated fulllength protein upon endosomal internalization. The numerical modelling of cell penetration and endosomal escape of the tested proteins has revealed a negative relationship between the amount of protein internalized into target cells and the efficiency of cytoplasmic release. This fact demonstrates that the His-mediated, proton sponge-based endosomal escape saturates at moderate amounts of internalized protein, a fact that might be critical for the design of protein materials for cytosolic molecular delivery.
INTRODUCTION
Proteins are versatile macromolecules whose structures and functional capabilities can be tailored by conventional genetic engineering. Among other regulatable properties, self-assembling can be achieved and controlled by protein engineering [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . By either peptide synthesis or recombinant DNA technologies, diverse categories of soft structures, including hydrogels, fibers, layers and nanoparticles can be fabricated [13, 14] . Being functional, these materials are assuming roles in biomedicine and nanomedicine, for regenerative medicine, diagnosis and drug delivery purposes. Protein nanoparticles are of particular interest as vehicles for drugs and imaging agents [15] . In this context, gene fusion technologies allow recruiting, in a single chain recombinant polypeptide, different functional peptides including self-assembling tags, endosomal escape regions and ligands of cell surface receptors [16] , necessary for nanoparticle formation and for cell-targeted delivery of any associated payload drug. The catalogues of receptors and their ligands are rapidly expanding, especially in oncology [17] , what allows empowering nanoparticles with appropriate cell ligands for attachment and cell internalization. The multivalent surface-display of ligands in multimeric nanoparticles, formed by multiple building blocks, promotes efficient endosomal internalization of the material in a virus-like fashion [18] . A particularly simple engineering procedure to generate protein nanoparticles is based on modular building blocks tagged with a hexahistidine tag (H6) at the carboxy termini [19, 20] , that coordinates divalent cations as a molecular cross-linker [21, 22] . The resulting family of oligomers, sizing around 10-30 nm, are highly stable in vivo and show an excellent tumor targeting mediated by alternative tumoral markers [23, 24] and ligands [25] [26] [27] . Because of the excellent biodistribution in mice models of human cancers, this category of His-based materials has been used in nanoconjugates or proteinonly nanoparticles to deliver small molecular weight drugs [28] , pro-apoptotic factors [29] and toxins [26, 30] in metastatic colorectal cancer, and potent plant cytotoxins in metastatic acute myeloid leukaemia [31] .
The peptide H6 is a critical component of such selfassembling platform, not only because of its architectonic properties but also as an endosomolytic agent [32] . The combination of both functions is very attractive when designing recombinant protein materials intended for endosomal delivery. Importantly, the application of toxin-based nanoparticles, immunotoxins or generically, protein-based drug vehicles [33, 34] , would largely benefit from potent endosomolytic agents. This is because lysosomal degradation is a critical bottleneck in the delivery route [35] , and in this context, many strategies and active materials are currently developed to enhance the necessary cytosolic delivery [36] [37] [38] [39] [40] . On the other side, proteins are becoming increasingly valuable biopharmaceuticals [34, [41] [42] [43] , and H6-based functionalization by gene fusion is a common procedure [44] . However, the use of H6 in clinics might be a source of regulatory concerns, since this peptide might be potentially immunogenic in humans [45] [46] [47] , what pushes to identify alternatives regarding both the nanoarchitectonic and endosomolytic properties of H6.
EXPERIMENTAL SECTION

Protein production and purification
Histidine-carrying modular proteins derived from the parental T22-GFP-H6 (30.69 kDa, Fig. 1 ), and the histidine-rich (Hn) sequences used here have a human origin (see Table 1 ). Further details of these proteins can be found elsewhere [48] . E. coli Origami B (BL21, OmpT − , Lon − , TrxB, Gor − ; Novagen) transformed cells were then grown at 37°C overnight in Lysogeny Broth (LB) and the encoded proteins were produced at 20°C overnight by the induction of gene expression with 0.1 mmol L −1 of isopropyl-β-D-thiogalactopyronaside (IPTG) at an optical density (OD) 550 of 0.5-0.7. Cells were harvested by centrifugation for 15 min (5,000 ×g at 4°C) and the pellets were stored at −80°C. Before use, the pellets were then thawed and resuspended in Wash buffer (20 NaCl, pH 8) buffers.
Protein purity, integrity and concentration, and nanoparticle formation
Protein purity was checked by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and western blot (WB) immunoassay by using a 1/500 dilution of anti-GFP monoclonal antibody (Santa Cruz Biotechnology). Protein concentration was determined by Bradford's assay, and integrity evaluated by matrixassisted laser desorption ionization time-of-flight (MAL-DI-TOF) mass spectrometry. The formation of protein nanoparticles was assessed by determining the volume size distribution by dynamic light scattering (DLS) at 633 nm and 25°C in a Zetasizer Nano ZS (Malvern Instruments Limited). For that, ZEN2112 3 mm quartz batch cuvettes were used in triplicate readings for error estimation, filled with protein samples at 1 mg mL −1 in carbonate buffer as described above.
Protein internalization and endosomal escape
HeLa CXCR4 + cells were cultured in 24-well plates (60,000 cells/well during 24 h for different time/concentration assays. 30,000 HeLa cells/well were cultured during 48 h for chloroquine (CQ) and AMD competition), in all cases using MEM Alpha 1× GlutaMAX TM medium (Gibco) supplemented with foetal bovine serum (FBS) at 37°C in a 5% CO 2 humidified atmosphere, reaching a confluence of 70%. Protein internalization was monitored by determining the cell green fluorescence after a harsh trypsin treatment at different exposure times. After exposure, the cells were detached and externally attached protein removed by adding Trypsin-EDTA (Gibco ® ) at 1 mg mL −1 for 15 min and 37°C. This is a particularly harsh trypsin treatment specifically developed to degrade cell surface-attached (but not internalized) protein, and aimed to prevent artefact readings from the contamination of externally attached fluorescent material [49] . Intracellular protein fluorescence was then determined by flow cytometry using a FACS-Canto system (Becton Dickinson) at 15 mW with an air-cooled argon ion laser exciting at 488 nm and corrected by the intrinsic fluorescence emission of each protein. Quantitative data are expressed as mean ± standard error. Additionally, the specific CXCR4-mediated protein internalization was probed by the addition of a CXCR4 antagonist (AMD3100) [50, 51] , which blocked the interaction between T22 (MRRWCYRKCYKGYCYRKCR) and CXCR4. This compound was added at a final concentration of 500 nmol L Fluorescence emission GFP fluorescence emission was determined at 510 nm using an excitation wavelength of 488 nm with a Varian Cary eclipse fluorescence spectrophotometer (Agilent Technologies). Before the measurement, proteins were equally diluted in their corresponding sodium carbonate without salt buffers to 1 mg mL −1 in a final volume of 100 µL.
Confocal imaging
HeLa CXCR4 + cells were cultured in MatTek (MatTek Corporation) plates (60,000 cells/well during 24h) using MEM Alpha 1× GlutaMAX TM medium (Gibco) supplemented with FBS at 37°C in a 5% CO 2 humidified atmosphere and exposed to 1 µmol L −1 of soluble protein for 24 h. Cell nuclei were then labelled with Hoechst 33342 (ThermoFisher) at 5 µg mL −1 , displaying blue sig- 
RESULTS
We have explored how several variants of Hn peptides in cell-targeted protein nanoparticles would perform regarding cell penetrability and endosome membrane activity. They derive from the parental T22-GFP-H6, a fusion protein that assembles as nanoparticles of 12 nm, which have been used for precision delivery of chemical drugs [28] and protein toxins [29, 30] into CXCR4 + tumor cells. Targeting is provided by the end-terminal peptide T22, a potent ligand of CXCR4 that promotes endosomal internalization [25] . To explore the impact of Hn in selfassembling, the H6 end-terminal peptide in T22-GFP-H6 had been replaced by the alternative histidine-rich peptides of similar length, H3A, H5T and H5E, corresponding to HAAHAH, HTHTHTHTH and HEHEHEHEH amino acid sequences respectively. These peptides show at least 90% of homology to sequences of human origin (Table 1) , and as in the case of T22-GFP-H6, they also promote the spontaneous formation of nanoparticles ranging from 10 to 18 nm [48] . In this context, we have comparatively characterized the Hn variant nanoparticles, namely T22-GFP-H3A, T22-GFP-H5T, T22-GFP-H5E and T22-GFP-H6 ( Fig. 1a inset, Table 1 ) regarding their interactivity with target CXCR4 + HeLa cells. No cell toxicity was observed in any of these materials upon exposure (Fig. 1a ), while all nanoparticles showed a comparable level of cell penetrability (Fig. 1b ). Uptake was, in all cases, dependent on the specific interaction of T22 with CXCR4, since the CXCR4 antagonist inhibited internalization with only a very low level of variability (from 95.5% to 97.2%, Fig. 1c ). At that point, endosomal escape was explored by using CQ, that prevents acidification and lysosomal protein degradation [40, 52] . The extent in which CQ enhances the fluorescence level is indicative of poor endosomal escape, while a null effect of the drug on the fluorescence would be indicative of a complete endosomal escape of the protein material. The addition of CQ to CXCR4 + HeLa cells in culture, before exposure to protein nanoparticles, showed a clearly differential impact on the intracellular fluorescence ( Fig. 1d) , indicating a distinguishable membrane activity of Hn variants. In Fig. 1e , representative images of HeLa cells exposed to nanoparticles are shown, highlighting the endosomal route of cell penetration. Because of such observed impact, we explored how the endosomal escape of the variant nanoparticles could be dependent on the number of histidine residues in the Hn tag. For that, we analyzed previously obtained physicochemical data on T22-GFP-H6 and T22-GFP-H5T, and fully characterized T22-GFP-H3A and T22-GFP-H5E (Table 1 ). All data sets were plotted versus the number of histidine residues in the Hn tags and plotted to evaluate potential correlations. As observed, cell internalization ( Fig. 2a ) and endosomal escape (Fig. 2b) were not dependent on the number of histidine residues, being these parameters probably influenced by features of the Hn tags less apparent than the histidine residue number. As an expected positive control, the amount of imidazole necessary for the elution of fusion proteins in His-based chromatographic purification was largely dependent on the Hn value ( Fig. 2c) . Interestingly, when plotting endosomal escape versus internalization, an unexpected but clear negative dependence was observed (Fig. 2d ). This observation might presumably reveal a general relationship between the receptor-dependent uptake of protein materials at the cell surface level and their ability to be released in the cytoplasm from uptaking vesicles. The possibility to unveil a generic mechanism in the cell penetrability of nanoparticles prompted us to further explore the endosome escape mechanisms of the Hn proteins, for what both internalization and endosomal escape were numerically modelled.
The model [53] that regulates the intensity of in- The typical evolution of f(t) and df/dt is displayed in Fig. 3a, b , where the blue line is for non-treated cells, the red line is for CQ-treated cells, and the green line measures the decay of fluorescence. The initial rate of intracellular fluorescence rising is ν≡(df/dt) t=0 =kL. Then, the fluorescence half-life can also be obtained as
The addition of CQ, that minimizes lysosomal proteolysis of the material, affects both k and L, and then, intracellular fluorescence evolves as described in the following differential approach
2
In the beginning, for f→0, the dominant term is accounted by the variation of k, namely df≈Ldk 2 /2. When f→∞, the dominant term is accounted by the variation of L, namely df≈LdlnL=dL. During the experimental time, f increases and the factor (L−f)/2 decreases. Hence, the first one will be prevalent. Their quotient 2f/(L−f) grows very fast and tends to 1 when 
Then, much earlier than for time t=τ, the first term becomes dominant. Furthermore, in the experimental data, the values dlnL~∆lnL are always greater than the values dk 2~∆ k 2 . The experimental data of CQ-treated cells (labelled with prime) are taken as reference. Then, we always obtain, as seen in Fig. S1a ,
It would be expected that at early times, before the proteolytic protective effects of CQ occur, the initial penetration rate would be the same in absence and in presence of the drug,
The plot in Fig. S1b indicates that this is nearly (but not completely) the case. It must be noted that the quotient ν/ Table 1 .
νʹ=1 is lost in samples with the highest relative variation of fluorescence L/Lʹ (Fig. S1c) . Also, the proportionality of Equation (2) is similar when comparing all samples (Fig. 3a, right) , but it is lost for high values of L.
In summary, the inverse relationship Equation (7) between L/Lʹ and fluorescence k/kʹ is accomplished (Fig. S2a) , and there is a clear negative correlation between the decrease of fluorescence and L in CQ-treated cultures (Fig. S2b) . Finally, the half-live growth is reduced when L increases (Fig. S1c) . Interestingly, ν=kL is nearly constant in absence and in presence of CQ, indicating that the drug acts predominantly at late endosome stages, and only in a residual (but detectable) way at early internalization phases.
The value a=0.8634 obtained in the fitting L−Lʹ =aLʹ (Fig. S2b) is coincident with the slope shown in Fig. 2d . This fully supports the concept that endosomal escape mediated by histidine residues is specially favored when low amounts of materials are internalized by the cells. On the contrary, cytosolic penetrability is inhibited, in relative terms, in the case of highly effective cell penetrating nanoparticles, indicating a saturation mechanism in the endosomal release of engulfed nanoparticles. As this fact has been profiled by the whole set of Hn-carrying materials, it might reflect a general law that at least should be valid for His-mediated endosomal escape processes of protein nanoparticles.
DISCUSSION
The peptide H6 is a widely spread tags for the one-step purification of recombinant proteins through Ni 2+ -based affinity chromatography [46, 54] . Upon purification, the presence of H6 or related peptides in the final protein product might have unexpected biological impacts, such as aberrant biodistribution of the protein or protein complex upon systemic injection [55, 56] . In this context, and also envisaging potential immunoreactions in protein materials intended for clinical use, the removal of H6 from purified proteins would be a desirable biotechnological step [44] . However, in the biological fabrication of protein-based materials, Hn peptides show interesting roles as architectonic tags as metal-dependent crossmolecular binders [12, 57, 58] . H6 has been efficiently used to force the formation of protein nanoparticles [21] , designed to transport either small molecular drugs [28] or cytotoxic proteins in cancer therapies [26, 31] . In addition, facing lysosomal degradation as a major bottleneck in the delivery of protein nanoparticles [40] , Hn peptides offer an added value to protein supramacromolecular complexes for intracellular delivery. In contrast to other diverse pathways of endosomal escape [40, 59] , Hn peptides promote endosomal escape of macromolecules and complexes by a proton-sponge mechanism [40] , that has not been so far investigated in deep. To combine the appealing properties of Hn peptides regarding protein purification, nanoparticle formation and endosomal escape, limiting potential immunotoxicity risks, we have explored the performance of several human or humanlike Hn peptides, previously explored as not immunogenic (Table 1 and references therein), regarding their ability to promote endosomal escape. In form of T22-GFP-Hn constructions, targeted to CXCR4 + cells through T22 [23] , the four tested Hn segments are not cytotoxic, penetrate target cells with high level of CXCR4dependence (then, by an endosomal route), and respond differentially to the presence of CQ (Fig. 1) , that prevents lysosomal destruction [52] . In particular, T22-GFP-H5E promotes an important endosomal escape slightly higher (23.66 %) than that triggered by H6 ( Fig. 1) . Even if the efficacy of H5E as an endosomolytic agent is not dramatically higher than that H6, the discovery of a humanized Hn version that performs slightly better than H6 in cytosolic delivery exemplifies the potential of optimized histidine tails to promote endosomal escape. In addition, the peptide HEHEHE does not promote hepatic accumulation of associated polypeptides [56, 60] , probably because of its hydrophilic nature when compared with similar Hn constructs [61] . As a side observation, we demonstrate that the presence of CQ enhances the intracellular permanence of uptaken proteins. Since CQ inhibits the acidification of endocytic vesicles [62] and the only type of endocytic vesicles that undergoes acidification is that based on clathrin [63] , the experimental data presented here strongly support that T22-empowered GFP-based nanoparticles exploit the clathrin-endosomal route for internalization. Interestingly, all T22-GFP-Hn particles bind specifically the cytokine receptor CXCR4 for cell internalization, as the CXCR4 antagonist AMD3100 blocks their entrance (Fig. 1c) . Also, CXCR4 is used by the human immunodeficiency virus as a co-receptor for cell infection [64] , and this virus enters cells via clathrin-mediated endocytosis [65] . Altogether, these data indicate that binding to CXCR4 favors consequent internalization by the clathrin-endosomal route.
In a more transversal context, when comparing the endosomal escape of the proteins (inversely correlating with the increase of intracellular fluorescence mediated by CQ) with the intensity of intracellular fluorescence, it rendered an unexpected negative correlation (Fig. 2d ). This fact was fully confirmed by an accurate dynamic modeling of the intracellular fluorescence upon exposure to the fluorescent proteins ( Fig. S2 ). This analysis strongly supports the concept that endosomal escape, as mediated by Hn peptides, is saturated at moderated amounts of internalized protein, what has critical implications in the design of nanoscale protein materials for intracellular drug delivery. For protein drugs [33, 43] , that are intrinsically sensitive to lysosomal destruction, developing agents to enhance cell penetrability might then result in a nonlinear gain in cytosolic delivery. However, regarding protein-drug conjugates, in which the effective drug is resistant to lysosomal activities, higher cell internalization should result in higher drug activity. Irrespective of that, we have here identified a set of humanized His-rich peptides that can be used as substitutes of H6 when engineering endosomal escape, which sufficiently keep the functionalities of H6 during chromatographic purifica-tion of recombinant proteins.
CONCLUSIONS
We have demonstrated here that humanized His-rich segments, with a number of His residues below 6, can efficiently promote endosomal escape of modular proteins targeted to CXCR4 + cells. In particular, the peptide HEHEHEHEH, appears as a promising tool to favor the intracellular trafficking and the proteolytic stability of the cargo protein, while it keeps the functional binding to Ni 2+ . The intensity of endosomal escape promoted by a series of humanized Hn peptides negatively correlates with the amount of internalized protein, revealing a saturation mechanism in the Hn-mediated cytosolic penetration. Finally, CQ, that mainly acts at the level of late endosomes, has a residual effect on the first stage of protein uptake, slightly enhancing the velocity of cellular penetration at the early endosome stages.
